Your browser doesn't support javascript.
loading
The impact of FDA regulatory activities on incident dispensing of LABA-containing medication: 2005-2011.
Baker, Meghan A; Butler, Melissa G; Seymour, Sally; Zhang, Fang; Wu, Yute; Wu, Ann Chen; Levenson, Mark S; Wu, Pingsheng; Iyer, Aarthi; Toh, Sengwee; Iyasu, Solomon; Zhou, Esther H.
Afiliação
  • Baker MA; a Department of Population Medicine , Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston , MA , USA.
  • Butler MG; b Division of Infectious Diseases, Department of Medicine , Brigham and Women's Hospital , Boston , MA , USA.
  • Seymour S; c Center for Clinical and Outcomes Research , Kaiser Permanente Georgia , Atlanta , GA , USA.
  • Zhang F; d The Evidence Space , Hamilton , Bermuda.
  • Wu Y; e Office of New Drugs, Center for Drug Evaluation and Research , Food and Drug Administration , Silver Spring , MD , USA.
  • Wu AC; a Department of Population Medicine , Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston , MA , USA.
  • Levenson MS; f Office of Biostatistics, Center for Drug Evaluation and Research , Food and Drug Administration , Silver Spring , MD , USA.
  • Wu P; a Department of Population Medicine , Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston , MA , USA.
  • Iyer A; f Office of Biostatistics, Center for Drug Evaluation and Research , Food and Drug Administration , Silver Spring , MD , USA.
  • Toh S; g Vanderbilt University School of Medicine , Department of Medicine and Biostatistics , Nashville , TN , USA.
  • Iyasu S; a Department of Population Medicine , Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston , MA , USA.
  • Zhou EH; a Department of Population Medicine , Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston , MA , USA.
J Asthma ; 55(8): 907-914, 2018 08.
Article em En | MEDLINE | ID: mdl-28910559

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / United States Food and Drug Administration / Revisão de Uso de Medicamentos / Antiasmáticos / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / United States Food and Drug Administration / Revisão de Uso de Medicamentos / Antiasmáticos / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article